CardioSignal
CardioSignal develops digital technologies and software-as-medical-devices to provide early detection of heart diseases, and provides the first and only technology to detect several major heart diseases with high accuracy using just one clinical modality without any specialized medical equipment.
CardioSignal is a brand and a product by Precordior Ltd, an ISO 13485 and 27001 certified health technology company formed in 2017 and headquartered in Turku, Finland. Subsidiary CardioSignal Inc is based in Palo Alto, CA, USA.
CardioSignal develops groundbreaking solutions for the detection of heart diseases using digital cardiac biomarkers.
The CardioSignal technology utilizes the gyroscope and accelerometer motion sensors to non-invasively measure heart motion to determine cardiac health and function.
Originally an academic spin-off, the company’s patented gyrocardiography technology is built on a decade of research and algorithm development.